Market Notice 134/20– Information regarding the rights issue from NextCell Pharma AB

The last day of trading in the company’s shares NXTCL including the right to receive subscription rights is June 1, 2020. The first day excluding the right to obtain the rights is June 2, 2020. 

One (1) share entitles the owner to two (2) subscription rights. Nine (9) subscription rights entitle the owner to subscribe for one (1) new share, at the price of SEK 5,90 (2:9 á SEK 5,90).   

Trading with subscription rights will take place from June 5, 2020 until June 17, 2020 on Spotlight Stock Market.   

Trading with the paid subscribed shares will take place from June 5, 2020 until the registration of the issue at Bolagsverket.   

The subscription period lasts from June 5, 2020 to June 22, 2020. 

Information about the subscription right:   

Short name: NXTCL TR 
ISIN-code: SE0014429056                     
Orderbook-ID: 6H4P 
CFI: RSSXXR 
FISN: NEXTCELLPH/SUBS RTS NL 
First day of trading: June 5, 2020 
Last day of trading: June 17, 2020 
Market Segment: SPSE 
MIC Code: XSAT 
Tick table/liquidity band #: A (Other instruments)

Information about the paid subscribed share:  

Shortname:NXTCL BTA 
ISIN-code: SE0014429064                     
Orderbook-ID: 6H4N 
CFI: ESNUFR 
FISN: NEXTCELLPH/SH   
Trading period: June 5, 2020 until the registration of the issue at Bolagsverket. 
Market Segment: SPSE 
MIC Code:  XSAT 
Tick table/liquidity band #: A (Other instruments)

Please be advised that if the rights issue give rise to a conversion factor, all overnight orders in the company’s orderbook will be deleted. If so this will occur after closing on June 1, 2020. 

Stockholm May 27, 2020 

Spotlight Stock Market 
08-511 68 000   
trading@spotlightstockmarket.com